Case Report: A case of immune checkpoint inhibitor therapy in a patient with multiple sclerosis

Raju Kumar Vaddepally; Soujanya Sodavarapu; Anupama Kutadi; Wesley Taylor; Navneeth Kumar

doi:https://doi.org/10.12688/f1000research.25490.1

doi.org/10.12688/f1000research.25490.1

Case Report: A case of immune checkpoint inhibitor therapy in a patient with multiple sclerosis

Raju Kumar Vaddepally

4

,

Soujanya Sodavarapu

1

,

..., Navneeth Kumar

F1000Research

Volume: 9, Pages: 1167 - 1167

Published: Sep 23, 2020

Abstract

Immune checkpoint inhibitors (ICIs) have rapidly shifted the landscape of treatments in malignancy with significant improvements in survival paradigm. They have been an attractive armamentarium to the oncologists given the limited immune adverse effects with potential for deeper and durable benefits that haven't been previously noticed with chemotherapy. However, they result in unique toxicities by limiting immune self-tolerance and cause...

Paper Fields

Paper Details

Title

Case Report: A case of immune checkpoint inhibitor therapy in a patient with multiple sclerosis

DOI

doi.org/10.12688/f1000research.25490.1

Published Date

Sep 23, 2020

Journal

F1000Research

Volume

9

Pages

1167 - 1167

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History